Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Saudi - Delayed Quote SAR

Al-Dawaa Medical Services Company (4163.SR)

Compare
79.90
-0.10
(-0.12%)
At close: 3:18:32 PM GMT+3
Loading Chart for 4163.SR
  • Previous Close 80.00
  • Open 80.00
  • Bid 79.90 x --
  • Ask 80.00 x --
  • Day's Range 79.60 - 80.80
  • 52 Week Range 65.80 - 98.20
  • Volume 117,257
  • Avg. Volume 162,814
  • Market Cap (intraday) 6.792B
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) 18.37
  • EPS (TTM) 4.35
  • Earnings Date --
  • Forward Dividend & Yield 3.14 (3.92%)
  • Ex-Dividend Date Feb 11, 2025
  • 1y Target Est 102.54

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on behalf of third parties, as well as acting as a pharmaceutical agent. The company sells its pharmaceutical products through a network of pharmacies, as well as online and wholesale channels. Further, it engages in the manufacture of single-use medical products, consumables, medical examination tables, surgical furniture, beds with mechanical motion additives, medical thermometers, respirators, and medical anesthesia solutions; granting marketing licenses for pharmaceutical products, consumer goods, and food products; and provision of health care management consulting, as well as delivery services via electronic platforms. The company was founded in 1993 and is based in Al Khobar, the Kingdom of Saudi Arabia.

www.al-dawaa.com.sa

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4163.SR

View More

Performance Overview: 4163.SR

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .

YTD Return

4163.SR
2.75%
Tadawul All Shares Index (^TASI.SR)
3.49%

1-Year Return

4163.SR
15.73%
Tadawul All Shares Index (^TASI.SR)
8.59%

3-Year Return

4163.SR
11.51%
Tadawul All Shares Index (^TASI.SR)
14.71%

5-Year Return

4163.SR
5.83%
Tadawul All Shares Index (^TASI.SR)
70.49%

Compare To: 4163.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4163.SR

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    6.80B

  • Enterprise Value

    8.85B

  • Trailing P/E

    18.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    4.67

  • Enterprise Value/Revenue

    1.37

  • Enterprise Value/EBITDA

    9.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.74%

  • Return on Assets (ttm)

    6.53%

  • Return on Equity (ttm)

    26.73%

  • Revenue (ttm)

    6.45B

  • Net Income Avi to Common (ttm)

    370.11M

  • Diluted EPS (ttm)

    4.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.32M

  • Total Debt/Equity (mrq)

    144.21%

  • Levered Free Cash Flow (ttm)

    321.2M

Research Analysis: 4163.SR

View More

Company Insights: 4163.SR

Research Reports: 4163.SR

View More

People Also Watch